8-KEarnings & ResultsExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Financial Results (Jul 26, 2023)

Filed July 26, 2023For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) filed an 8-K on July 26, 2023, primarily to report its financial results for the quarter ended June 30, 2023. While the filing itself is brief, it directs investors to an attached press release (Exhibit 99.1) for detailed operational and financial performance information. Investors should review this press release for specific figures related to revenue, earnings, and any forward-looking statements or guidance provided by the company. The core purpose of this filing is to ensure public disclosure of material financial information in a timely manner. Investors relying on this report should understand that the 8-K serves as a notification and incorporation by reference to the more comprehensive earnings announcement. Therefore, the real substance of the company's quarterly performance, management's commentary, and future outlook will be found within the press release itself, which is considered an integral part of this filing.

Key Highlights

  • 1Quest Diagnostics (DGX) filed an 8-K on July 26, 2023, to announce Q2 2023 financial results.
  • 2The filing incorporates by reference a press release (Exhibit 99.1) containing the detailed financial and operational results.
  • 3Investors should refer to Exhibit 99.1 for specific Q2 2023 earnings data, revenue figures, and company performance metrics.
  • 4The 8-K serves as a formal mechanism for disclosing material financial information to the public.
  • 5No specific financial figures or operational details are provided directly within the 8-K filing itself; they are in the referenced press release.

Frequently Asked Questions

The main purpose of this 8-K filing by Quest Diagnostics is to officially announce and report its financial results for the quarter ended June 30, 2023, and to make the associated press release publicly available.

The detailed financial results, along with operational performance and management's commentary, are located in the press release attached as Exhibit 99.1 to this 8-K filing. This exhibit is incorporated by reference into the 8-K.

No, the 8-K filing itself does not directly list specific financial numbers. It serves as a notification and directs investors to the press release (Exhibit 99.1) for those details.

Investors should focus on the content of the press release (Exhibit 99.1) to understand Quest Diagnostics' Q2 2023 financial performance, including revenue, profitability, key business drivers, and any forward-looking guidance or outlook provided by the company.